Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
adipose-derived stem cells (Pell Bio-Med Technology)
- Development stage
- Preclinical
- Lead developer
- Pell Bio-Med Technology
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Local Injection
01
Overview
Adipose-derived stem cells (ADSC) are a type of mesenchymal stem cell (MSC) developed by Pell Bio-Med Technology for use in regenerative medicine and cell therapy. These cells are harvested from adipose tissue and possess multipotent differentiation potential, allowing them to develop into various cell types such as chondrocytes, osteoblasts, and adipocytes. Beyond their differentiation capacity, ADSCs function by secreting a variety of paracrine factors, including growth factors and cytokines, which promote tissue repair, stimulate angiogenesis, and modulate immune responses to reduce inflammation. Pell Bio-Med Technology lists ADSCs as part of its commercial product portfolio, where they are typically applied in clinical settings for indications such as osteoarthritis, chronic wound healing, and soft tissue regeneration, often within the regulatory framework of Taiwan's 'Special Act' for cell therapies.
- Other names
- adipose-derived stem cellsadipose-derived mesenchymal stem cellsadipose-derived stromal cells
Beyond the preview
Go deeper on adipose-derived stem cells (Pell Bio-Med Technology).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on adipose-derived stem cells (Pell Bio-Med Technology).